ClinicalTrials.gg
Active, not recruitingNCT07010783Updated Oct 29, 2026

Respiratory Functions in Parkinson's Disease

An observational study in Parkinson Disease, sponsored by Ankara University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Ankara University · Observational

How we know

Updated Oct 29, 2026Now Active, not recruitingPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
50 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 172 studies in Parkinson Disease with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Parkinson Disease · Turkey.

Planned enrollment
12th of 73
100 · median 61
Started
2025
with 32 others
Observational
73 of 172
23 open now
Primary completion
2026-12
later than 37 of 55 live
Registered
110th of 172
by date
Lead sponsor
6 of 172
Ankara University

Among the 172 studies in Parkinson Disease with a site in Turkey, this one is the 12th largest by planned enrollment of the 73 observational ones that give a count, is one of 33 that started in 2025, is one of 73 observational ones, reaches primary completion later than 37 of the 55 other live ones, and was the 110th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

50 of the 172 studies in Parkinson Disease with a site in Turkey are open now. Recruiting first, the newest first:

45 more — sign in →

All 50 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 50 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 172 studies in Parkinson Disease with a site in Turkey, or all of them as a file.
02

Study summary

The aim is to examine respiratory functions, inspiratory muscle strength, respiratory function, physical fitness and aerobic capacity in Parkinson's disease patients. Individuals between the ages of 50-80 who have been diagnosed with Parkinson's disease by a neurologist and healthy individuals with similar demographic characteristics will be included in the study as a control group. In addition, patients will be divided into three groups as above and below 2.5 and healthy controls according to the Modified Hoehn and Yahr Scale. Demographic information of the individuals will be recorded and clinical evaluations will be made. The staging of Parkinson's patients will be done with the Modified Hoehn and Yahr Scale, and the severity of the disease will be done with the Unified Parkinson's Disease Rating Scale. The inspiratory muscle strength of the individuals will be evaluated with the PowerBreath K5, respiratory functions with the Pulmonary Function Test device, and physical fitness and aerobic capacity with the Senior Fitness Test.

03

Conditions studied

  • Parkinson Disease

Browse trials for

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with Parkinson's disease who came to the neurology outpatient clinic for routine examination and who met the appropriate inclusion criteria and healthy individuals with similar demographic characteristics.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 50 to 80
  • score of 24 to 30
  • Diagnosed with Parkinson's Disease by a neurologist

Exclusion criteria

Exclusion Criteria:

  • Sözlü iletişim kuramama
  • Yürüme yardımcısı kullanıma
  • Ciddi görme bozukluğu, ek nörolojik bozuklukları ve/veya konjestif kalp yetmezliği olan yaşlılar
  • Egzersiz yapılması tavsiye edilmeyen yaşlı yetişkinler.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Early Stage Patients with Parkinson's Disease

    According to the Modified Hoehn and Yahr Scale (MHÖ), patients with a score below 2.5

  • Advanced Stage Patients with Parkinson's Disease

    According to the Modified Hoehn and Yahr Scale (MHÖ), patients with 2.5 and above

  • Control Group

    Healthy individuals with similar demographic characteristics

06

What researchers measure

Primary outcomes

  1. Inspiratory Muscle Strength Measurement

    In this study, the inspiratory muscle strength of the participants will be measured using the Power Breath device.

    Time frame: Baseline

  2. Unified Parkinson's Disease Rating Scale

    This scale will evaluate the severity and stage of the participants' Parkinson's disease.

    Time frame: Baseline

  3. Evaluation of Respiratory Functions

    Participants' respiratory functions will be evaluated using a standard respiratory function test device.

    Time frame: Baseline

  4. Senior Fitness Test

    The physical fitness levels of the participants will be evaluated using the Senior Fitness Test.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Publications

  • Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin Neurosci. 1998;5(2):131-5. PubMed 10785839 ↗
  • Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1532-4. doi: 10.1136/jnnp.57.12.1532. PubMed 7798986 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Dec 2026, 17 months after the start.

Of 381 non-industry observational studies under Parkinson Disease, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 133. This study's planned 17 months is below that.

Counting every sponsor, half of 441 studies reached it within 47 months; a quarter within 22 and three quarters within 114.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Apr 2026 → Dec 2026 and completion May 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2025
First posted
Jun 8, 2025
StartActual
Jul 1, 2025
Primary completionEst.
Dec 1, 2026was Apr 2026
CompletionEst.
Dec 20, 2026was May 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 29, 2026
Primary completion
Apr 2026→Dec 1, 2026
Oct 29, 2026
Study completion
May 2026→Dec 20, 2026
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Recruiting→Active, not recruiting
    Primary completion Apr 2026→Dec 1, 2026
    Study completion May 2026→Dec 20, 2026
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07010783
Lead sponsor
Ankara University
Collaborators
Hacettepe University, Atılım University
Responsible party
Büşra Seçkinoğulları Korkusuz (Principal Investigator, Ankara University) — Principal investigator
First posted
Jun 8, 2025
Start date
Jul 1, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 20, 2026 (estimated)
Last update
Oct 29, 2026

Study contacts

Süleyman Korkusuz, PhD
study chair · Atılım University
Ayla Fil Balkan, Assoc Prof
study chair · Hacettepe University
Gül Yalçın Çakmaklı, Assoc Prof
study chair · Hacettepe University
Neslihan Durutürk, Prof.Dr
study chair · Baskent University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion